NDC 59762-2010-01 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-2010
- Requested NDC
- 59762-2010-01
- Package NDCs from labels
- 59762-2010-9, 59762-2010-3, 59762-2010-1, 59762-2010-01
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2024-11-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2024-11-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-2010-1 | amlodipine besylate | 1000 in 1 BOTTLE | TABLET | 1000 | 32 | |
| 59762-2010-3 | amlodipine besylate | 300 in 1 BOTTLE | TABLET | 300 | 32 | |
| 59762-2010-9 | amlodipine besylate | 90 in 1 BOTTLE | TABLET | 90 | 32 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-2010 | AMLODIPINE BESYLATE TABLET [MYLAN PHARMACEUTICALS INC.] | 31 | Current NDC, Legacy NDC, 3 package rows | 20250502_180ee374-24f2-4b9c-9d54-8815f2b1dc9b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-2010-1 | EA - Each | 59762-2010 | 02138dd6-d473-4892-b0ae-8c78a8d4437f | 1 | 2019-07-02 |
| 59762-2010-3 | EA - Each | 59762-2010 | 51b3ff67-f1e1-4b68-8f57-97363b780902 | 1 | 2019-07-02 |
| 59762-2010-9 | EA - Each | 59762-2010 | baddac96-f6f2-46c8-a173-93e23006f4f3 | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMLODIPINE BESYLATE | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| AMLODIPINE | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Cardinal Health 107, LLC | a74239bf-4684-424c-ba4e-6087e363265b | 2026-04-09 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Amneal Pharmaceuticals NY LLC | 856a8cdc-57cc-4355-966d-986bbc5fa6e6 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | 6f20efca-943b-4bc2-a157-0931bd4d4585 | 2026-03-28 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 5f7a4bd1-8083-46ca-95f2-e8c476b5367c | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | bed1710f-edd9-488d-855b-603d50ee212c | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | ff807933-7433-4f8c-9d09-02a57e51d0fc | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | ba6f6ab5-b65a-4486-b994-2d8bbbe650af | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 5d7ca186-f22b-465f-913b-c020240b2c66 | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 50112e22-5a69-47c9-90cd-82bbacae7418 | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 9654e50b-811a-4c89-b1ab-f48418b204c1 | 2026-03-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | f16e04b5-57b9-49cc-811b-07d85ccb5d9f | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Legacy Pharmaceutical Packaging, LLC | 2cdd0da9-eea6-45e0-b0b7-35413a168a4f | 2026-03-03 | Warnings, Adverse reactions | 197361 308135 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Legacy Pharmaceutical Packaging, LLC | 215ef2cb-d5b6-43d5-bbd5-195ec57cde2b | 2026-03-03 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aurobindo Pharma Limited | b6f298ba-2d7e-4a3c-9edb-8b60aba716d6 | 2026-03-03 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | b25681a9-7b0e-40f9-844e-ec4842e3713c | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 1df35c9b-0cd8-41f4-b9d4-8f51ba57b3e0 | 2026-02-26 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | a6635bb3-b8d5-4046-ac56-27af9bac877e | 2026-02-26 | Warnings, Adverse reactions | 308135 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | aec7618e-c9da-431f-8b6a-14aa399242f6 | 2026-02-25 | Warnings, Adverse reactions | 197361 864V2Q084H |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | ea9f44a1-96cf-496a-8c07-18d8de27e512 | 2026-02-25 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | 4e6bf47a-ee8a-4083-8cce-a6a25260d3fb | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.